What is the prevalence of Small for Gestational Age?

Small for Gestational Age (SGA) is a clinical term, not a single disease, defined by a birth weight below the 10th percentile for gestational age. Globally, it is estimated to affect approximately 10% of all newborns, though this prevalence varies significantly based on regional population-specific growth charts and socioeconomic factors.

Is Small for Gestational Age considered a rare disease?

While Small for Gestational Age is common in a global health context, it is not a uniform diagnosis. Because it is a description of size rather than a single genetic pathology, it is not classified as an "ultra-rare" disease. However, when Small for Gestational Age persists into childhood or adulthood—often referred to as short stature due to SGA—the underlying causes can involve rare endocrine or genetic conditions, which are far less common.

How does the incidence of Small for Gestational Age vary?

The incidence of Small for Gestational Age depends heavily on the reference population used. In developed countries, the 10th percentile is the standard threshold. Key factors influencing prevalence include:

• Geographic variation: Higher rates are observed in low-to-middle-income countries due to maternal nutritional status and infectious disease exposure.


• Gender distribution: Male infants are statistically more likely to be classified as Small for Gestational Age than female infants in many global datasets.


• Data challenges: Accurate prevalence is often obscured by the use of non-standardized growth charts and inconsistent reporting of gestational dating.

What is the age of onset and community experience?

The onset of Small for Gestational Age is strictly prenatal, identified at birth. While most infants experience "catch-up growth" by age two, a subset remains shorter than their peers, requiring long-term monitoring. At DiseaseMaps.org, 21 people currently sharing their journey with Small for Gestational Age provide a vital, real-world perspective on the long-term health outcomes and the diagnostic odyssey that some families face when seeking to understand why their child remained small.

Next steps

• Consult a pediatric endocrinologist if your child has not achieved catch-up growth by age 2 to 4.


• Track growth milestones using standardized, population-specific growth charts.


• Connect with the 21 members of the DiseaseMaps.org community to share experiences and management strategies.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment.

References

• World Health Organization (WHO) - Global Nutrition Targets 2025: Low Birth Weight Policy Brief.


• NIH Genetic and Rare Diseases Information Center (GARD) - Resources on Intrauterine Growth Restriction.


• Orphanet - Rare diseases associated with short stature and prenatal growth failure.


• Journal of Pediatrics - Longitudinal studies on catch-up growth in SGA cohorts.